Artiva Biotherapeutics, Inc. files current report with SEC

Artiva Biotherapeutics, Inc. filed an 8-K/A covering SEC Item 2.05. Nelo verified the filing topics against the primary SEC document. This is a company disclosure filed with the SEC, not an SEC enforcement action.